Learning About Lowering LDL-C
Elevated LDL-C is directly associated with the development of ASCVD. Learn about current treatments, barriers in applying guideline-directed therapies, strategies for prioritizing LDL-C in clinical practice, combatting misinformation, and utilizing…
Read MoreGaps in Applying Current Guidelines for LDL-C Lowering
Hypercholesterolemia continues to be one of the primary modifiable risk factors for cardiovascular disease (CVD), yet cholesterol management remains an ongoing challenge for healthcare professionals and patients. In this article,…
Read MoreThe Role of Lp(a) in CVD Risk
Expand your knowledge of cardiovascular health with this comprehensive Lipoprot(a) course and its impact on cardiovascular disease (CVD) risk. Examine cutting-edge research focused on strategies to lower Lp(a) levels and…
Read MoreLp(a): Closer Than You Think [CE Podcast]
Kathy Byrne, MSN, CRNP, CCRN.,and Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, describe the most common genetic dyslipidemia–elevated lipoprotein (a), or Lp(a). The discussion includes testing for Lp(a)–especially cascade screening for…
Read MoreLurking Lp(a): Hiding Just Below the Surface [CE Podcast]
While Lp(a) levels are generally hereditary in nature, other factors can cause elevated levels. Learn about current guidelines-directed medical therapies, and how Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, and Kathy…
Read MoreThe Buck Stops Here: We’re All Responsible for Lp(a) [CE Podcast]
Cindy Lamendola, MSN, NP, FAHA, FPCNA, describes the impacts of elevated Lp(a) on the body. Current clinical trials and the necessity of including diverse participants are described, as well as…
Read MoreWe’re All Responsible for Lp(a)
Guest Cindy Lamendola, MSN, NP, FAHA, FPCNA, describes the impacts of elevated Lp(a) on the body. Current clinical trials and the necessity of including diverse participants are described, as well…
Read MoreLurking Lp(a): Hiding Just Below the Surface
While Lp(a) levels are generally hereditary in nature, other factors can cause elevated levels. Learn about current guidelines-directed medical therapies, and how guests Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, and…
Read MoreLp(a): Closer to Home Than You Think
Guests Kathy Byrne, MSN, CRNP, CCRN.,and Lisa Maher, DNP, ARNP, FNP-BC, FPCNA, describe the most common genetic dyslipidemia–elevated lipoprotein (a), or Lp(a). The discussion includes testing for Lp(a)–especially for family…
Read MoreAccess to Lipid Lowering Medications
Join Dr. Handberg to review novel lipid-lowering medications on the market today and examine the effect of social determinants of health on access and adherence to lipid-lowering medications. Patient Advocate…
Read More